Abstract Diagnosing stable ischemic heart disease (IHD) is challenging, especially in females. Currently, no blood test is available. Plasma extracellular vesicles (EV) are emerging as potential biomarker source. We therefore aimed to identify stress induced ischemia due to stable IHD with plasma extracellular vesicle protein levels in chest pain patients. We analyzed 450 patients suspected for stable IHD who were referred for 82Rb PET/CT in the outpatient clinic. Blood samples were collected before PET/CT and plasma EVs were isolated in 3 plasma subfractions named: TEX, HDL, LDL. In total 6 proteins were quantified in each of these subfractions using immuno-bead assays. CD14 and CystatinC protein levels were independent significant predict...
AimsExtracellular vesicles (EVs) were investigated as potential biomarkers associated with heart fai...
Plasma extracellular vesicle (EV) number and composition are altered following myocardial infarction...
Coronary artery disease (CAD), comprising both acute coronary syndromes (ACS) and chronic coronary s...
BackgroundDespite the use of high-sensitive cardiac troponin there remains a group of high-sensitive...
BACKGROUND: Despite the use of high-sensitive cardiac troponin there remains a group of high-sensiti...
Extracellular vesicles (EVs) are submicron, membrane-enclosed particles that are released from cells...
SerpinF2, SerpinG1, CystatinC and CD14 are involved in inflammatory processes and plasma extracellul...
BACKGROUND: SerpinF2, SerpinG1, CystatinC and CD14 are involved in inflammatory processes and plasma...
Cardiovascular disease is a major public health problem worldwide. Its growing burden is particularl...
Myocardial infarction (MI) triggers a potent inflammatory response via the release of circulatory me...
Myocardial infarction (MI) triggers a potent inflammatory response via the release of circulatory me...
Aims: Extracellular vesicles (EVs) are small double-membrane plasma vesicles that play key roles in ...
Aims Increased shedding of extracellular vesicles (EVs)—small, lipid bilayer-delimited particles wit...
Background: In patients with established cardiovascular disease, high levels of the extracellular ve...
Background: Rapid and accurate new biomarkers to predict risk of cardiovascular disease (CVD) are es...
AimsExtracellular vesicles (EVs) were investigated as potential biomarkers associated with heart fai...
Plasma extracellular vesicle (EV) number and composition are altered following myocardial infarction...
Coronary artery disease (CAD), comprising both acute coronary syndromes (ACS) and chronic coronary s...
BackgroundDespite the use of high-sensitive cardiac troponin there remains a group of high-sensitive...
BACKGROUND: Despite the use of high-sensitive cardiac troponin there remains a group of high-sensiti...
Extracellular vesicles (EVs) are submicron, membrane-enclosed particles that are released from cells...
SerpinF2, SerpinG1, CystatinC and CD14 are involved in inflammatory processes and plasma extracellul...
BACKGROUND: SerpinF2, SerpinG1, CystatinC and CD14 are involved in inflammatory processes and plasma...
Cardiovascular disease is a major public health problem worldwide. Its growing burden is particularl...
Myocardial infarction (MI) triggers a potent inflammatory response via the release of circulatory me...
Myocardial infarction (MI) triggers a potent inflammatory response via the release of circulatory me...
Aims: Extracellular vesicles (EVs) are small double-membrane plasma vesicles that play key roles in ...
Aims Increased shedding of extracellular vesicles (EVs)—small, lipid bilayer-delimited particles wit...
Background: In patients with established cardiovascular disease, high levels of the extracellular ve...
Background: Rapid and accurate new biomarkers to predict risk of cardiovascular disease (CVD) are es...
AimsExtracellular vesicles (EVs) were investigated as potential biomarkers associated with heart fai...
Plasma extracellular vesicle (EV) number and composition are altered following myocardial infarction...
Coronary artery disease (CAD), comprising both acute coronary syndromes (ACS) and chronic coronary s...